4//SEC Filing
Subramanian Sanjay 4
Accession 0001192482-21-000754
CIK 0001372299other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 4:01 PM ET
Size
6.5 KB
Accession
0001192482-21-000754
Insider Transaction Report
Form 4
Ocugen, Inc.OCGN
Subramanian Sanjay
Chief Financial Officer
Transactions
- Award
Option (Right to Buy)
2021-11-16+35,560→ 35,560 totalExercise: $5.64Exp: 2031-04-19→ Common Stock (35,560 underlying)
Footnotes (2)
- [F1]Represents the closing price of Ocugen, Inc.'s (the "Company") common stock on the date of grant. See footnote 2 below.
- [F2]On April 19, 2021, the Reporting Person was granted a performance-based option to purchase 177,800 shares of the Company's common stock based on the Company's satisfaction of five performance criteria prior to the end of the Company's 2021 and 2022 fiscal years, as applicable (the "Performance-Based Option"). With respect to each performance criteria, 10% of the Performance-Based Option vests on the date of the Compensation Committee's determination that the applicable criteria has been achieved (each, a "Determination Date") and an additional 10% vests upon the first anniversary of the applicable Determination Date, subject to the grantee's continued service with the Company on such date. On November 16, 2021, the Compensation Committee determined that one of the performance criteria had been achieved, resulting in the Performance-Based Option vesting in part as to 35,560 shares. 17,780 shares of the Performance-Based Option are immediately vested and exercisable, with the remaining 17,780 shares vesting on November 16, 2022, subject to the Reporting Person's continued service with the Company.
Documents
Issuer
Ocugen, Inc.
CIK 0001372299
Entity typeother
Related Parties
1- filerCIK 0001790246
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 4:01 PM ET
- Size
- 6.5 KB